Artificial Intelligence

A new multi-year deal for advanced battery materials highlights Volkswagen's push for supply chain control and Cabot's strategic green energy pivot.

The San Diego-based credit union is partnering with the AI lending giant to expand loan access, signaling a major shift in how local finance competes.

Celebrating 60 years, Sensormatic Solutions unveils new AI and RFID tools to fight shrink, boost inventory accuracy, and transform the shopper experience.

Lifepoint Health partners with iScribeHealth, deploying ambient AI scribes across its network to reduce documentation and improve patient care.

Triad Partners' 'Launch 2026' event features Alex Rodriguez and an AI mastermind to help financial advisors redefine success and build lasting legacies.

Cynomi hires ThreatLocker's former CRO Shane Deegan, signaling a major push to help MSPs turn cybersecurity from a cost center into a profit engine.

Mundial Media and Grupo Reforma's exclusive deal uses AI to analyze cultural context, offering a privacy-safe way to reach Hispanic audiences at scale.

With a new CEO known for scaling tech giants, Planview is doubling down on its AI-first platform to dominate the strategic portfolio management market.

Associated Food Stores is deploying FORM's advanced retail tech, giving its 500 independent members new tools to optimize shelves and challenge major chains.

At CES 2026, an ice cream-scooping robot reveals PaXini's full-stack plan to solve embodied AI's biggest challenges with advanced tactile sensors and data.

The deal merges digital orchestration with field AI, promising pharma a unified, rapid-deployment engagement solution to challenge industry giants.

Teal Health's FDA-authorized Teal Wand is now available in all 50 states, aiming to revolutionize preventive care for millions of overdue women.

A Boston biotech, armed with $62M and a new name, unveils a plan to build a universal model of the cell, aiming to predict and control its behavior.

Wearable Devices and Rokid partner to bring touchless gesture control to smart glasses, promising a future where a flick of a finger runs your world.

A new AI receptionist integrated into HawkSoft aims to end missed calls and manual data entry. But are independent agencies ready to trust the technology?

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

With $16.4M in new funding, STRM.BIO is advancing a novel gene therapy platform that uses natural vesicles to target bone marrow, offering new hope for rare diseases.

Palisade Bio's PALI-2108, a drug targeting IBD at its source, secures a key investment, offering hope for a new era of treatment with fewer side effects.

Navan CEO Ariel Cohen will pitch his growth strategy at the Needham conference, a key test for the travel tech firm amid stock declines and high hopes.

A new global study shows consumers embrace AI for product research but don't trust it for purchases, revealing a 'Confidence Economy' ruled by transparency.